Abstract
Purpose
The interactions between grapefruit juice (GFJ) and tacrolimus (FK506) metabolism remain obscure. The aim of this prospective study was to explore the effect of GFJ on the blood concentration of FK506 in liver transplant patients.
Methods
Thirty liver transplant patients were enrolled in the study 1 month post-transplant and randomly divided into three equal-sized groups. Group A patients were treated with the standard FK506-based immunosuppressant regimen only and therefore served as the control; group B and C patients were treated with the standard FK506-based immunosuppressant regimen as well as one of two different kinds of GFJ, respectively. The blood concentrations of FK506 on the seventh day after GFJ intake were compared within each group and among groups. The dose of FK506 was adjusted depending on the valley concentration measured to a treatment window.
Results
The blood concentration of FK506 in both group B and group C patients was significantly enhanced, by 1.56 ± 0.95 and 10.33 ± 5.59 ng/ml, respectively, following the administration of GFJ for 1 week (compared with the concentration at the start of the experiment in each group; p < 0.05). However, at the end time point, the blood concentration of FK506 in group C patients was significantly increased (p < 0.05) relative to that of the control patients, while this was not the case in group B patients (p > 0.05). Group C patients could be treated with a smaller dose of FK506 (decreased by 2.3 ± 1.3 mg/day for all patients; p = 0.011), amounting to a decrease in drug costs of approximately $8.70 ± 5.60/day (p = 0.011).
Conclusion
In the setting of a controlled clinical study, the co-administration of GFJ with FK506 increased the bioavailability of FK506. However, the concentration of tacrolimus should be closely monitored and the dose adjusted to the treatment window.
Similar content being viewed by others
References
US Multicenter FK506 Liver Study Group (1994) A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 331:1110–1115
European FK506 Multicentre Liver Study Group (1994) Randomised trial comparing tacrolimus (FK506) and cyclosporine in prevention of liver allograft rejection. Lancet 344:423–428
Bailey DG, Spence JD, Munoz C et al (1991) Interaction of citrus juices with felodipine and nifedipine. Lancet 337:268–269
Bailey DG, Malcolm J, Arnold O et al (1998) Grapefruit juice-drug interactions. Br J Clin Pharmacol 46:101–110
Dresser GK, Bailey DG (2003) The effects of fruit juices on drug disposition: a new model for drug interactions. Eur J Clin Invest 33:10–16
Staatz CE, Tett SE (2004) Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation. Clin Pharmacokinet 43:623–653
Fukatsu S, Fukudo M, Masuda S et al (2006) Delayed effect of grapefruit juice on pharmacokinetics and pharmacodynamics of tacrolimus in a living-donor liver transplant recipient. Drug Metab Pharmacokinet 21:122–125
Iwasaki K (2007) Metabolism of tacrolimus (FK506) and recent topics in clinical pharmacokinetics. Drug Metab Pharmacokinet 22:328–335
Staatz CE, Tett SE (2004) Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation. Clin Pharmacokinet 43:623–653
Hesselink DA, Van Schaik RH, van der Heiden IP et al (2003) Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus. Clin Pharmacol Ther 74:245–254
Kane GC, Lipsky JJ (2000) Drug–grapefruit juice interactions. Mayo Clin Proc 75:933–942
Uno T, Yasui-Furukori N (2006) Effect of grapefruit juice in relation to human pharmacokinetic study. Curr Clin Pharmacol. 1:157–161
Egashira K, Ohtani H, Itoh S et al (2004) Inhibitory effects of pomelo on the metabolism of tacrolimus and the activities of CYP3A4 and P-glycoprotein. Drug Metab Dispos 32:828–833
Nagy J, Schipper HG, Koopmans RP et al (2002) Effect of grapefruit juice or cimetidine coadministration on albendazole bioavailability. Am J Trop Med Hyg 66:260–263
Paine MF, Widmer WW, Pusek SN et al (2008) Further characterization of a furanocoumarin-free grapefruit juice on drug disposition: studies with cyclosporine. Am J Clin Nutr 87:863–871
Parker RB, Yates CR, Soberman JE et al (2003) Effects of grapefruit juice on intestinal P-glycoprotein: Evaluation using digoxin in humans. Pharmacotherapy 23:979–987
Christensen H, Asberg A, Holmboe AB, Berg KJ (2002) Coadministration of grapefruit juice increases systemic exposure of diltiazem in healthy volunteers. Eur J Clin Pharmacol 58:515–520
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liu, C., Shang, YF., Zhang, XF. et al. Co-administration of grapefruit juice increases bioavailability of tacrolimus in liver transplant patients: a prospective study. Eur J Clin Pharmacol 65, 881–885 (2009). https://doi.org/10.1007/s00228-009-0702-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-009-0702-z